Biologics Market Research Reports & Industry Analysis
The biologics industry includes a wide range of therapeutic products derived from biological sources and is a fundamental part of modern healthcare. Biologics play a vital role in advancing treatments for various diseases and conditions. MarketResearch.com offers a comprehensive collection of biologics industry reports to provide valuable insights into the most recent market trends, challenges, and opportunities to watch.
Biologics Market Growth Forecasts
- Access detailed information about a variety of distinct market segments, such as recombinant proteins, vaccines, and more.
- Obtain biologics market sizing and growth projections to gain a clear understanding of market potential and outlook.
- Analyze leading players and competitor strategies to stay one step ahead in a competitive market.
The MarketResearch.com Advantage
MakretResearch.com has been a trailblazer in the field of market research for more than two decades and continues to serve many of the largest life science and biotech companies in the world. With MarketResearch.com’s reliable data-driven insights, you can make informed decisions to guide your business towards success. Choose MarketResearch.com and gain the edge today.
Biologics Industry Research & Market Reports
-
Lab Instrumentation Markets for Pharmaceuticals & Biopharmaceuticals, 2024
... tackling complex cancers and rare diseases, the importance of this industry can’t be overstated. However, creating an ideal therapeutic is not a strait forward process. An illness must be identified, and an early stage of ... Read More
-
Peptide Synthesis
... at a CAGR of 4.3% over the analysis period 2023-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the ... Read More
-
Spine Biologics
... at a CAGR of 4.4% over the analysis period 2023-2030. Spinal Allografts, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Orthobiologics
... of 4.1% over the analysis period 2023-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth ... Read More
-
Biopharmaceuticals Manufacturing Consumables Testing
... reach US$1.1 Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2023-2030. Compendial & Multi Compendial Laboratory Testing, one of the segments analyzed in the report, is expected to record a ... Read More
-
Plasma Protein Therapeutics
... by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Albumin, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$9.3 Billion by the ... Read More
-
Lyophilization Services For Biopharmaceuticals Global Market Opportunities And Strategies To 2033
... Cartridges3) By Application: Pharmaceutical And Biotechnology Companies; Research InstitutesCovering: PCI Pharma Services; OFD LLC (Oregon Freeze Dry); Simtra BioPharma Solutions (Baxter); Vetter Pharma-Fertigung GmbH & Co. KG; IDT Biologika GmbH Lyophilization Services For Biopharmaceuticals Global ... Read More
-
Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033
... Organizations; Contract Research Organizations; Academic Research InstitutesCovering: Danaher Corporation; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Sartorius Stedim Biotech; Getinge Group Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033 from The Business ... Read More
-
Age-related Macular Degeneration (AMD) Drugs Market by Product (Lucentis, Eylea & Eylea HD, Vabysmo, Syfovre), Molecule (Ranibizumab, Aflibercept, Faricimab), Approval Type (Biologic, Biosimilar), Type of AMD, End User - Global Forecast to 2029
... Macular Degeneration (AMD) Drugs market is projected to reach USD 17.37 Billion from 2029 USD 10.46 Billion in 2024 growing at a CAGR of 10.7% during the forecast period of 2024-2029. Major pharmaceutical companies have ... Read More
-
Global Genotyping Market Size Study, By Product (Instruments, Reagents & Kits, Software and Services), By Technology (PCR, Capillary Electrophoresis, Microarrays, Sequencing, Mass Spectrometry, Others), By Application (Pharmacogenomics, Diagnostics and Personalized Medicine, Agricultural Biotechnology, Animal Genetics, Others), By End-Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others), and Regional Forecasts 2022-2032
... Others), By End-Use (Pharmaceutical and Biopharmaceutical Companies, Diagnostics and Research Laboratories, Academic Institutes, Others), and Regional Forecasts 2022-2032 The Global Genotyping Market is estimated to be valued at approximately USD 2.42 billion in 2023 and ... Read More
-
Global Ornithine Transcarbamylase (OTC) Deficiency Treatment Market Growth (Status and Outlook) 2024-2030
... 2023. With growing demand in downstream market, the Ornithine Transcarbamylase (OTC) Deficiency Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report ... Read More
-
Global SUT Rocking Bioreactors Market (2024 Edition): Market Size, Trends, Opportunities and Forecast by Application (Vaccine Production, Gene Therapy, Cell Culture, Biopharmaceutical Manufacturing and Other Applications), End-User, Product Type, Region, By Country: 2020-2030
... report published by Azoth Analytics highlights different factors and opportunities prevailing in the “Global SUT Rocking Bioreactors Market (2024 Edition)”. According to the report, Global SUT Rocking Bioreactors Market was valued at USD 3865.13 Million ... Read More
-
3D Bioprinting Market Report by Component (3D Bioprinters, Scaffolds, Biomaterials), Application (Research, Clinical), End User (Hospitals, Research Organization and Academic Institutes, Biopharmaceuticals Companies), and Region 2024-2032
... Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 4,281.9 Million by 2032, exhibiting a growth rate (CAGR) of 14.7% during 2024-2032. The growing geriatric population, increasing focus on research and ... Read More
-
Biological Safety Testing Market Report by Product and Services (Kits and Reagents, Instruments, Services), Test Type (Endotoxin Tests, Sterility Tests, Cell Line Authentication and Characterization Tests, Bioburden Tests, Residual Host Contaminant Detection Tests, Adventitious Agent Detection Tests, and Others), Application (Vaccine Development, Blood Products Testing, Cellular and Gene Therapy, Tissue and Tissue-related Products Testing, Stem Cell Research), and Region 2024-2032
... Detection Tests, and Others), Application (Vaccine Development, Blood Products Testing, Cellular and Gene Therapy, Tissue and Tissue-related Products Testing, Stem Cell Research), and Region 2024-2032 The global biological safety testing market size reached US$ 4.4 ... Read More
-
Psoriatic Arthritis Treatment Market Report by Drug Type (NSAIDs (Nonsteroidal Anti-Inflammatory drugs), DMARDs (Disease-Modifying Anti-Rheumatic Drugs), Biologics, and Others), Type (Prescription, OTC), Route of Administration (Injectable, Oral, Topical), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2024-2032
... Pharmacies), and Region 2024-2032 The global psoriatic arthritis treatment market size reached US$ 9.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.8 Billion by 2032, exhibiting a growth rate ... Read More
-
Next Generation Sequencing Market Analysis and Forecast to 2033: By TYPE (RNA Sequencing, Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, De Novo Sequencing), TECHNOLOGY (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies), APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals & Clinics, Contract Research Organizations, Diagnostic Laboratories, Forensic Labs, Agricultural Research Centers, Government & Regulatory Agencies), PRODUCT (Sequencing, Data Analysis, Sample Preparation, Target Enrichment, Others), WORKFLOW (NGS Library Preparation Kits, Semi-automated Library Preparation, Automated Library Preparation, Sequenc
... Other Technologies), APPLICATION (Diagnostics, Oncology, Research Applications, Clinical Investigation, Reproductive Health, Drug Discovery, HLA Typing/Immune System Monitoring, Metagenomics and Epidemiology, Consumer Genomics, Agricultural & Animal Research), END-USER (Academic & Research Institutions, Biopharmaceutical & Biotechnology, Hospitals ... Read More
-
Biopharmaceutical Industry Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... 2029, growing at a CAGR of 7.56% during the forecast period (2024-2029). The COVID-19 pandemic had a significant impact on the biopharmaceutical industry. Thus, biopharma industry trends shifted to most biopharmaceutical companies striving extensively to ... Read More
-
Bioprocess Containers
... at a CAGR of 23.6% over the analysis period 2023-2030. Upstream Processes Application, one of the segments analyzed in the report, is expected to record a 26.4% CAGR and reach US$19.6 Billion by the end ... Read More
-
Fill Finish Manufacturing
... by 2030, growing at a CAGR of 8.6% over the analysis period 2023-2030. for Fill Finish Manufacturing Consumables, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach ... Read More
-
Bioburden Testing
... growing at a CAGR of 9.8% over the period 2023-2030. Bioburden Testing Consumables, one of the segments analyzed in the report, is expected to record 10.2% CAGR and reach US$1.3 Billion by the end of ... Read More
-
Biologics Safety Testing
... by 2030, growing at a CAGR of 11.8% over the analysis period 2023-2030. Biologics Safety Testing Services, one of the segments analyzed in the report, is expected to record a 12.1% CAGR and reach US$5.5 ... Read More
-
Burn Care
... at a CAGR of 4.0% over the analysis period 2023-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.5 Billion by the end ... Read More
-
Cell and Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type [Cell Therapy (Allogeneic, Autologous, and Viral Vectors) and Gene Therapy (Non-Viral Vectors, and Viral Vectors)], Services (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre Commercial/R and D Manufacturing and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, and Academic and Research Institutes), and Geography
... Vectors, and Viral Vectors)], Services (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre Commercial/R and D Manufacturing and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), End User (Contract Research Organizations, Pharmaceutical ... Read More
-
Global Contract Development & Manufacturing Organization (CDMO) Market: Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... for the period spanning 2024-2028. The factors such as increasing per capita disposable income, increasing global healthcare expenditure, rising aging population, increasing R&D spending, growing number of new drugs, rise in investments and strategic collaborations ... Read More
-
Global Upstream Bioprocessing Market Size study, by Product (Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactor Accessories, Bags & Containers, Other Products), by Usage Mode (Multi-use, Single-use), by Mode (In-house, Outsourced), by Application (Monoclonal Antibody Production, Vaccine Production, Cell and Gene Therapy Production, Other Applications), by End-user (Biopharmaceutical Companies, CDMOs and CROs, Research and Academic Institutes) and Regional Forecasts 2022-2032
... Production, Cell and Gene Therapy Production, Other Applications), by End-user (Biopharmaceutical Companies, CDMOs and CROs, Research and Academic Institutes) and Regional Forecasts 2022-2032 Global Upstream Bioprocessing Market is valued at approximately USD 9.54 billion in ... Read More
Research Assistance
